as 12-18-2024 9:47am EST
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
Upcoming Earnings Alert:
Get ready for potential market movements as Cryo-Cell International Inc. CCEL prepares to release earnings report on 24 Dec 2024.
Founded: | 1989 | Country: | United States |
Employees: | N/A | City: | OLDSMAR |
Market Cap: | 50.0M | IPO Year: | 1997 |
Target Price: | N/A | AVG Volume (30 days): | 13.9K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | Dividend Payout Frequency: | N/A | |
EPS: | -1.09 | EPS Growth: | N/A |
52 Week Low/High: | $4.47 - $9.50 | Next Earning Date: | 12-24-2024 |
Revenue: | $31,838,476 | Revenue Growth: | 1.95% |
Revenue Growth (this year): | 3.97% | Revenue Growth (next year): | 0.91% |
CCEL Breaking Stock News: Dive into CCEL Ticker-Specific Updates for Smart Investing
Business Wire
2 months ago
Business Wire
2 months ago
Business Wire
5 months ago
GOBankingRates
6 months ago
AFP
6 months ago
AFP
6 months ago
Bloomberg
6 months ago
AFP
6 months ago
The information presented on this page, "CCEL Cryo-Cell International Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.